טוען...
Cancer-targeted therapies and radiopharmaceuticals
The treatment of bone metastases remains a clinical challenge. Although a number of well-established agents, namely bisphosphonates and denosumab, are available to reduce the occurrence of skeletal-related events, additional cancer-targeted therapies are required to improve patients' prognosis...
שמור ב:
| הוצא לאור ב: | Bonekey Rep |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4455688/ https://ncbi.nlm.nih.gov/pubmed/26131359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bonekey.2015.76 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|